000 01183 a2200301 4500
005 20250514164539.0
264 0 _c20040220
008 200402s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.48.1.366-367.2004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKitzis, M D
245 0 0 _aIn vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJan 2004
300 _a366-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aDrug Resistance, Multiple, Bacterial
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMinocycline
_xanalogs & derivatives
650 0 4 _aStaphylococcus aureus
_xdrug effects
650 0 4 _aStreptococcus pneumoniae
_xdrug effects
650 0 4 _aTetracyclines
_xpharmacology
650 0 4 _aTigecycline
700 1 _aLy, A
700 1 _aGoldstein, F W
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 48
_gno. 1
_gp. 366-7
856 4 0 _uhttps://doi.org/10.1128/AAC.48.1.366-367.2004
_zAvailable from publisher's website
999 _c14424443
_d14424443